Objectives:
Carnitine deficiency has been implicated as a potential pathway for cancer-related fatigue that could be treated with carnitine supplementation. Therefore, this review article (meta-analysis) has been conducted.
Does carnitine supplementation reduce cancer-related fatigue?
Study design:
This review article included 3 RCTs involving a total of 659 participants.
There were not enough studies to conduct sensitivity analyses to isolate potential sources of heterogeneity and test the robustness of findings.
Results and conclusions:
The investigators found in 3 RCTs involving a total of 659 participants that carnitine supplementation did not significantly reduce cancer-related fatigue [SMD = 0.06 points, 95% CI = -0.09 to 0.21, p = 0.45, I2 = 0%].
Clinical heterogeneity was evident from these studies in regards to the dose (2-4 g of carnitine per day), patient demographics (40-100% females included) and carnitine status.
The investigators concluded there is no evidence to support the use of carnitine supplementation (2-4 g of carnitine per day) for cancer-related fatigue.
Original title:
Efficacy and Effectiveness of Carnitine Supplementation for Cancer-Related Fatigue: A Systematic Literature Review and Meta-Analysis by Marx W, Teleni L, [...], Isenring E.
Link:
http://www.mdpi.com/2072-6643/9/11/1224/htm
Additional information of El Mondo:
Find more information/studies on carnitine, randomized controlled trials/cohort studies/subgroup analysis and cancer right here.